Citation: | Xu Chao, Mo Ying, Ni Hai-feng, Liu Bi-cheng, Wang Feng-mei, Zhang Lei. One case report of proliferative glomerulonephritis with monoclonal immunoglobulin G3-kappa deposits with HCV hepatitis infection[J]. Journal of Clinical Nephrology, 2021, 21(5): 431-434. DOI: 10.3969/j.issn.1671-2390.w20-197 |
[1] |
Nasr SH,Markowitz GS,Stokes MB,et al.Proliferative glomerulonephritis with monoclonal IgG deposits:a distinct entity mimicking immune-complex glomerulonephritis[J].Kidney Int,2004,65(1):85-96.DOI: 10.1111/j.1523-1755.2004.00365.x.
|
[2] |
Xing GL,Gillespie R,Bedri B,et al.Proliferative glomerulonephritis with monoclonal IgG deposits in children and young adults[J].Pediatr Nephrol,2018,33(9):1531-1538.DOI: 10.1007/s00467-018-3949-8.
|
[3] |
Kousios A,Duncan N,Tam FWK,et al.Proliferative glomerulonephritis with monoclonal Ig deposits(PGNMID):diagnostic and treatment challenges for the nephrologist![J].Kidney Int,2019,95(2):467-468.DOI: 10.1016/j.kint.2018.10.016.
|
[4] |
Spatola L,Generali E,Angelini C,et al.HCV-negative mixed cryoglobulinemia and kidney involvement:in-depth review on physiopathological and histological bases[J].Clin Exp Med,2018,18(4):465-471.DOI: 10.1007/s10238-018-0514-5.
|
[5] |
Markowitz GS,Cheng JT,Colvin RB,et al.Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy[J].J Am Soc Nephrol 1998,9(12):2244-2252.
|
[6] |
Kanda T,Lau GKK,Wei L,et al.APASL clinical practice recommendation:how to treat HCV-infected patients with renal impairment?[J].Hepatol Int,2019,13(2):103-109.DOI: 10.1007/s12072-018-9915-5.
|
[7] |
Sise ME,Bloom AK,Wisocky J,et al.Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents[J].Hepatology,2016,63(2):408-417.DOI: 10.1002/hep.28297.
|
[8] |
Saadoun D,Pol S,Ferfar Y,et al.Efficacy and safety of sofosbuvir plus daclatasvir for treatment of HCV-associated cryoglobulinemia vasculitis[J].Gastroenterology,2017,153(1):49-52.e5.DOI: 10.1053/j.gastro.2017.03.006.
|
[9] |
Cao YL,Zhang YK,Wang SX,et al.Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis[J].Nephrol Dial Transplant,2009,24(9):2745-2751.DOI: 10.1093/ndt/gfp167.
|
[10] |
Gupta A,Quigg RJ.Glomerular Diseases Associated With Hepatitis B and C[J].Adv Chronic Kidney Dis,2015,22(5):343-351.DOI: 10.1053/j.ackd.2015.06.003
|
[11] |
Yu XJ,Hu N,Wang SX,et al.Membranoproliferative glomerulonephritis with deposition of monoclonal IgG evolved from polyclonal IgG:a case report with two consecutive renal biopsies[J].BMC Nephrol,2019,20(1):275.DOI: 10.1186/s12882-019-1453-4.
|
[12] |
Li LL,Li ZY,Wang SX,et al.Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis[J].BMC Nephrol,2019,20(1):459.DOI: 10.1186/s12882-019-1640-3.
|
[13] |
Gumber R,Cohen JB,Palmer MB,et al.A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits[J].Kidney Int,2018,94(1):199-205.DOI: 10.1016/j.kint.2018.02.020.
|